HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qingqing Chai Selected Research

Therapeutics

1/2022Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis.
10/2014Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice.
5/2014Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qingqing Chai Research Topics

Disease

8Infections
10/2022 - 01/2013
2Rabies (Hydrophobia)
10/2014 - 05/2014
1Body Weight (Weight, Body)
04/2023
1Triple Negative Breast Neoplasms
04/2023
1Breast Neoplasms (Breast Cancer)
11/2022
1Vesicular Stomatitis
10/2022
1Neoplasms (Cancer)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Bites and Stings (Sting)
01/2018
1Neurocognitive Disorders (Clerambault Syndrome)
11/2017
1Alzheimer Disease (Alzheimer's Disease)
11/2017
1Dementia (Dementias)
11/2017

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
10/2022 - 05/2014
2CytokinesIBA
01/2015 - 05/2014
2ChemokinesIBA
01/2015 - 05/2014
1sacituzumab govitecanIBA
04/2023
1Trastuzumab (Herceptin)FDA Link
11/2022
1ErbB Receptors (EGF Receptor)IBA
11/2022
1Biosimilar PharmaceuticalsIBA
11/2022
1Hemagglutinins (Hemagglutinin)IBA
10/2022
1MannosidasesIBA
10/2022
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2022
1MucinsIBA
10/2022
1RestonIBA
10/2022
1Bos taurus structural-GP proteinIBA
10/2022
1concanamycin AIBA
10/2022
1bafilomycin A1IBA
10/2022
1nitazoxanide (NTZ)FDA Link
10/2022
1lactacystinIBA
10/2022
1tizoxanideIBA
10/2022
1X-Box Binding Protein 1IBA
10/2022
1Histone Deacetylase 6IBA
10/2022
1CRISPR-Associated Protein 9IBA
10/2022
1Cycloheximide (Cicloheximide)IBA
10/2022
1Glycoproteins (Glycoprotein)IBA
10/2022
1Heat-Shock Proteins (Heat-Shock Protein)IBA
10/2022
1Phosphotransferases (Kinase)IBA
10/2022
1Double-Stranded RNA (RNA, Double Stranded)IBA
10/2022
1ThioredoxinsIBA
10/2022
1Transcription Factors (Transcription Factor)IBA
10/2022
1ThapsigarginIBA
10/2022
1Protein Disulfide-IsomerasesIBA
10/2022
1UbiquitinIBA
10/2022
1CalnexinIBA
10/2022
1CalreticulinIBA
10/2022
1Prokaryotic Initiation Factor-2IBA
10/2022
1alpha-Mannosidase (LAMAN)IBA
10/2022
1Lysosomal Membrane ProteinsIBA
10/2022
1atezolizumabIBA
01/2022
1PlatinumIBA
01/2022
1NivolumabIBA
01/2020
1InterferonsIBA
01/2018
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2018
1Amyloid beta-PeptidesIBA
11/2017
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
01/2017
1Neutralizing AntibodiesIBA
10/2014
1OccludinIBA
05/2014
1Claudin-5IBA
05/2014
1Tight Junction ProteinsIBA
05/2014
1FlagellinIBA
01/2013

Therapy/Procedure

3Drug Therapy (Chemotherapy)
04/2023 - 01/2020
3Therapeutics
01/2022 - 05/2014